Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 200 Total
UPC - Universe Pharmaceuticals INC - Stock Price Chart
TickerUPC [NASD]
CompanyUniverse Pharmaceuticals INC
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap8.58MEPS (ttm)-1.70
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.27EPS next 5Y-
P/B0.22EPS Q/Q47.96%
Dividend-Sales Q/Q-13.17%
Insider Own57.05%Inst Own0.18%
Insider Trans0.00%Inst Trans-97.11%
Short Float0.25%EarningsJan 30/a
Analyst Recom-Target Price-
Avg Volume89.75K52W Range0.75 - 5.88
Feb-20-24 08:32AM Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today? (InvestorPlace) -28.46%
Jan-30-24 04:30PM Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results (PR Newswire) -14.64%
Aug-04-23 08:30AM Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares (GlobeNewswire) -6.83%
Jul-27-23 10:15AM Universe Pharmaceuticals INC Announces Share Consolidation (GlobeNewswire) +6.33%
Mar-07-23 08:00AM Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Dec-21-22 08:00AM Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (GlobeNewswire)
Nov-14-22 08:00AM Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Aug-16-22 08:00AM Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022 (PR Newswire)
Jul-19-22 06:00AM Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Mar-30-22 08:00AM Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms (GlobeNewswire)
CMPS - Compass Pathways Plc ADR - Stock Price Chart
TickerCMPS [NASD]
CompanyCompass Pathways Plc ADR
CountryUnited Kingdom
IndustryMedical Care Facilities
Market Cap526.49MEPS (ttm)-2.39
P/E-EPS this Y5.14%
Forward P/E-EPS next Y2.76%
PEG-EPS past 5Y-
P/S-EPS next 5Y3.40%
P/B2.33EPS Q/Q27.54%
Dividend-Sales Q/Q-
Insider Own8.94%Inst Own32.57%
Insider Trans-18.66%Inst Trans1.68%
Short Float5.92%EarningsMay 08/b
Analyst Recom1.00Target Price41.25
Avg Volume651.03K52W Range5.01 - 12.75
Today 04:45AM Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript (Motley Fool)
May-08-24 06:45AM Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
06:30AM Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder (GlobeNewswire)
May-03-24 04:58PM Compass Pathways to announce first quarter financial results on May 8, 2024 (GlobeNewswire)
May-02-24 06:30AM Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment (GlobeNewswire)
Apr-29-24 06:30AM Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression (GlobeNewswire)
Apr-01-24 04:01PM Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire) +16.35%
Mar-31-24 05:47PM 20 Most Depressed Countries in Asia (Insider Monkey)
Mar-28-24 08:00AM Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors (GlobeNewswire) -12.42%
Mar-19-24 08:00AM The Next Great Biotech Boom Has Arrived (PR Newswire)
RENB - Renovaro Inc. - Stock Price Chart
TickerRENB [NASD]
CompanyRenovaro Inc.
CountryUSA
IndustryBiotechnology
Market Cap209.76MEPS (ttm)-0.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-19.64%
P/S-EPS next 5Y-
P/B2.25EPS Q/Q14.32%
Dividend-Sales Q/Q-
Insider Own28.97%Inst Own1.89%
Insider Trans0.00%Inst Trans-1.58%
Short Float2.16%Earnings-
Analyst Recom-Target Price-
Avg Volume356.89K52W Range0.39 - 5.25
Apr-30-24 11:00AM Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics (GlobeNewswire)
Apr-24-24 09:00AM RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
Apr-18-24 08:45AM Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99%
Feb-15-24 09:25AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
Jan-18-24 09:30AM Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
DBGI - Digital Brands Group Inc - Stock Price Chart
TickerDBGI [NASD]
CompanyDigital Brands Group Inc
CountryUSA
IndustryApparel Retail
Market Cap4.23MEPS (ttm)-42.50
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y55.29%
P/S0.27EPS next 5Y-
P/B1.73EPS Q/Q98.29%
Dividend-Sales Q/Q-17.36%
Insider Own9.35%Inst Own0.70%
Insider Trans0.00%Inst Trans-46.90%
Short Float2.18%EarningsApr 15/a
Analyst Recom-Target Price-
Avg Volume1.26M52W Range2.30 - 33.50
May-07-24 04:51PM DBGI Announces Closing of Exercise of Warrants for $3.2 Million in Gross Proceeds (GlobeNewswire)
May-03-24 09:18AM DBGI Announces Exercise of Warrants for $3.2 Million in Gross Proceeds (GlobeNewswire) -7.82%
Apr-15-24 09:52PM DBGI Stock Earnings: Digital Brands Group Reported Results for Q4 2023 (InvestorPlace)
04:15PM Digital Brands Group Reports Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire)
Apr-12-24 11:00AM Digital Brands Group to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, April 15, 2024 (PR Newswire) +7.95%
Feb-27-24 06:42PM Digital Brands Group to open its first store in April with more to come (Chain Store Age) -7.31%
08:30AM Digital Brands Group To Open First Retail Store in First Half of April in Dallas, Texas (PR Newswire)
Feb-13-24 02:36PM Why Is Digital Brands (DBGI) Stock Up 150% Today? (InvestorPlace) +139.09%
08:30AM DBGI Reaffirms its 2024 Guidance and Commits to No Equity Offerings for 2024 (PR Newswire)
Jan-18-24 07:55PM Parent of digital-first apparel brands to enter physical retail with 50 stores (Chain Store Age) -6.64%
AVTX - Avalo Therapeutics Inc - Stock Price Chart
TickerAVTX [NASD]
CompanyAvalo Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap12.08MEPS (ttm)-381.56
P/E-EPS this Y99.20%
Forward P/E-EPS next Y-6.59%
PEG-EPS past 5Y49.49%
P/S6.26EPS next 5Y-
P/B1.29EPS Q/Q95.92%
Dividend-Sales Q/Q-36.27%
Insider Own7.28%Inst Own17.57%
Insider Trans0.00%Inst Trans-27.29%
Short Float15.98%EarningsMar 29/a
Analyst Recom1.00Target Price35.00
Avg Volume685.15K52W Range3.95 - 1130.40
Apr-02-24 11:30AM Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why (Zacks) -15.31%
07:00AM Avalo Therapeutics Appoints Biotech Leaders to Board of Directors (GlobeNewswire)
Mar-29-24 04:01PM Avalo Reports 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-28-24 08:04AM Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today? (InvestorPlace) +357.89%
Mar-27-24 04:01PM Avalo Acquires Anti-IL-1 mAb and Announces Private Placement Financing of up to $185 Million (GlobeNewswire)
10:00AM Will Avalo Therapeutics, Inc. (AVTX) Report Negative Q4 Earnings? What You Should Know (Zacks)
Feb-26-24 11:28AM Avalo (AVTX) to Report Q4 Earnings: What's in the Cards? (Zacks)
Dec-27-23 07:00AM Avalo Therapeutics Announces 1-for-240 Reverse Stock Split (GlobeNewswire)
Dec-07-23 07:00AM Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split (GlobeNewswire) -5.61%
Nov-09-23 07:00AM Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -10.09%
NCI - Neo Concept International Group Holdings Ltd - Stock Price Chart
TickerNCI [NASD]
CompanyNeo Concept International Group Holdings Ltd
CountryHong Kong
IndustryApparel Manufacturing
Market Cap22.56MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume3.38M52W Range0.93 - 11.39
May-08-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +12.92%
Apr-25-24 12:18PM Neo-Concept International Group Holdings Limited Announced Closing of Initial Public Offering (GlobeNewswire)
Apr-23-24 06:05AM Neo-Concept International Group Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq (GlobeNewswire)
SGBX - Safe & Green Holdings Corp - Stock Price Chart
TickerSGBX [NASD]
CompanySafe & Green Holdings Corp
CountryUSA
IndustryMetal Fabrication
Market Cap4.80MEPS (ttm)-33.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y40.46%
P/S0.29EPS next 5Y-
P/B-EPS Q/Q-184.15%
Dividend-Sales Q/Q-52.32%
Insider Own34.90%Inst Own3.39%
Insider Trans0.00%Inst Trans-
Short Float2.27%EarningsApr 15/a
Analyst Recom1.00Target Price56.24
Avg Volume1.98M52W Range2.01 - 27.00
May-08-24 08:30AM Safe & Green Holdings Reports Year-End 2023 Results (GlobeNewswire) +9.54%
May-06-24 08:00AM Safe & Green Holdings Corp Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -12.45%
May-03-24 09:00AM Safe & Green Holdings' Subsidiary, SG Echo, to Deliver First Eco-Friendly Modular Unit to Prominent Quick-Service Restaurant Customer in the Pacific Northwest (GlobeNewswire) +89.08%
May-02-24 08:30AM Safe and Green Holdings Announces Collaboration and Sales of Modular Units to Britten Inc. (GlobeNewswire) +32.94%
Apr-30-24 10:15AM Correction: Safe & Green Holdings Corp Announces Reverse Split of the Company's Common Stock (GlobeNewswire) -18.30%
09:28AM Safe & Green Holdings Corp Announces Reverse Split of the Company's Common Stock (GlobeNewswire)
Apr-25-24 09:00AM Safe & Green Holdings Announces it Has Entered Into an Agreement to Produce Four Modular Electrical Distribution Centers as Part of a Multi-Unit Order for a Client Serving the Big Box Retailer Market (GlobeNewswire) +51.98%
Apr-24-24 08:30AM Safe & Green Holdings Corp. Announces Receipt of Nasdaq Notification (GlobeNewswire)
Apr-19-24 09:00AM Safe & Green Holdings Corp Provides Update on Its Audit and Planned 10-K Filing for the Year Ended December 31, 2023 (GlobeNewswire)
Apr-15-24 04:05PM Safe & Green Holdings Corp to Report Financial Results and File Its Form 10-K for the Year Ended December 31, 2023, on April 16, 2024 (GlobeNewswire)
GREE - Greenidge Generation Holdings Inc - Stock Price Chart
TickerGREE [NASD]
CompanyGreenidge Generation Holdings Inc
CountryUSA
IndustryCapital Markets
Market Cap25.85MEPS (ttm)-3.32
P/E-EPS this Y72.06%
Forward P/E-EPS next Y-43.16%
PEG-EPS past 5Y36.24%
P/S0.35EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q26.67%
Insider Own33.24%Inst Own6.07%
Insider Trans0.18%Inst Trans7.88%
Short Float5.86%EarningsMay 02/a
Analyst Recom1.00Target Price6.00
Avg Volume258.34K52W Range1.55 - 9.26
May-01-24 04:00PM Greenidge Generation Announces Preliminary Financial and Operating Results for the First Quarter 2024 and Release of Investor Presentation (Business Wire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-10-24 08:30AM Greenidge Generation: Q4 Profit Beats Its Previous Guidance (RTT News) -8.02%
08:00AM Greenidge Generation Reports Financial and Operating Results for the Fourth Quarter and Full Year 2023 (Business Wire)
Apr-04-24 09:00AM Greenidge Announces Continued Expansion of Power Capacity; Company Has Secured Access To 60 MW of Low-Cost Power in South Carolina (Business Wire)
Mar-27-24 04:00PM Greenidge Generation Announces Fourth Quarter Results Will Meet or Exceed Preliminary Results (Business Wire) +7.38%
Mar-11-24 09:00AM Greenidge Announces Expansion of Power Capacity with 40 MW of Low-Cost Power in Key Territories (Business Wire)
Feb-12-24 09:00AM Infinite Reality, the Global Leader in Immersive Experiences, Acquires Spatial Web Pioneer Ethereal Engine (GlobeNewswire) +6.51%
08:00AM Greenidge Generation Announces $6 Million Investment to Support Ongoing Business Transformation (Business Wire)
Feb-01-24 08:00AM Greenidge Generation Announces Favorable Preliminary Financial and Operating Results for the Fourth Quarter 2023 (Business Wire)
ELYM - Eliem Therapeutics Inc - Stock Price Chart
TickerELYM [NASD]
CompanyEliem Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap258.35MEPS (ttm)-1.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-46.72%
P/S-EPS next 5Y-
P/B2.40EPS Q/Q55.35%
Dividend-Sales Q/Q-
Insider Own33.48%Inst Own60.83%
Insider Trans0.00%Inst Trans-1.61%
Short Float3.26%Earnings-
Analyst Recom3.00Target Price24.00
Avg Volume878.35K52W Range2.34 - 11.55
Apr-11-24 02:42PM Eliem Therapeutics Shifts From Neurology With New Found Focus On Autoimmune Diseases With Tenet Medicines Deal (Benzinga) +71.54%
07:00AM Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement (GlobeNewswire)
Apr-05-24 06:53AM ELYM Stock Earnings: Eliem Therapeutics Reported Results for Q4 2023 (InvestorPlace) -6.81%
Jul-21-23 07:17AM Eliem (ELYM) to Explore Strategic Options, Stock Rises 6% (Zacks) -8.39%
Jul-20-23 06:45AM Eliem Therapeutics Announces Plans to Explore Strategic Alternatives (GlobeNewswire) +6.43%
May-11-23 04:10PM Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights (GlobeNewswire) -10.22%
Apr-21-23 12:00PM We're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wisely (Simply Wall St.)
10:39AM Top 10 Stocks Activist Investors Are Targeting (Insider Monkey)
Mar-06-23 04:10PM Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights (GlobeNewswire)
Feb-23-23 12:38AM Eliem Therapeutics slashing staff amid leadership shakeup (American City Business Journals) +24.35%
AGL - Agilon Health Inc - Stock Price Chart
TickerAGL [NYSE]
CompanyAgilon Health Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap2.13BEPS (ttm)-0.56
P/E-EPS this Y33.88%
Forward P/E-EPS next Y54.88%
PEG-EPS past 5Y7.65%
P/S0.42EPS next 5Y-
P/B3.09EPS Q/Q-82.45%
Dividend-Sales Q/Q41.21%
Insider Own26.31%Inst Own84.96%
Insider Trans0.02%Inst Trans1.84%
Short Float15.19%EarningsMay 07/a
Analyst Recom2.41Target Price6.93
Avg Volume4.70M52W Range4.41 - 26.75
May-08-24 05:45AM agilon health, inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL (PR Newswire)
03:57AM Agilon Health Inc (AGL) Q1 2024 Earnings Call Transcript Highlights: Robust Growth Amidst ... (GuruFocus.com)
May-07-24 09:00PM AGL Stock Earnings: Agilon Health Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM Agilon (AGL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:00PM Agilon Health Inc (AGL) Q1 2024 Earnings: Aligns with EPS Projections Despite Revenue Surge (GuruFocus.com)
04:00PM agilon health Reports First Quarter 2024 Results (Business Wire)
03:55PM agilon health Announces New Physician Partnerships for 2025 (Business Wire)
Apr-16-24 04:00PM agilon health Sets Date to Report First Quarter 2024 Financial Results (Business Wire)
Apr-15-24 07:15AM NYSE: AGL Lawsuit Notice: Investors who lost money with shares of agilon health, inc. (NYSE: AGL) should contact the Shareholders Foundation (GlobeNewswire) -9.90%
Apr-08-24 06:25AM agilon health, inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 20, 2024 to Discuss Your Rights - AGL (PR Newswire) +9.05%
1⋯91011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.